Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

Alan Mateo Biography and Net Worth

EVP of Veeva Systems

Alan Mateo is the executive vice president of global sales for Veeva Systems, Inc., a company that serves the life sciences industry through cloud-based software solutions. He has held this position since 2015.

Throughout his career, Mateo has managed high-performing sales teams and fostered strategic relationships. Previously, he spent ten years at Medidata Solutions, Inc., a leader in cloud-based solutions platform for life sciences in various executive roles. Before that, he spent eleven years with PeopleSoft, Inc., where he oversaw product lines sales, sales operations, and the integration of J.D. Edwards into the company’s sales organizations with a combined revenue of over $2.5 billion.

Before joining PeopleSoft, Mateo was the northeast sales director at Red Pepper Software Co., a provider of supply chain management planning application software. Early in his career, Mateo was an account executive for J.D. Edwards.

Mateo attended Juniata College and holds a B.S. in computer science and marketing. He resides in Pleasanton, California where Veeva is headquartered.

What is Alan Mateo's net worth?: The estimated net worth of Alan Mateo is at least $4.93 million as of April 23rd, 2024. Mr. Mateo owns 21,983 shares of Veeva Systems stock worth more than $4,927,489 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Mateo may own. Learn More about Alan Mateo's net worth.
How do I contact Alan Mateo?: The corporate mailing address for Mr. Mateo and other Veeva Systems executives is 4280 HACIENDA DRIVE, PLEASANTON CA, 94588. Veeva Systems can also be reached via phone at (925) 452-6500 and via email at [email protected]. Learn More on Alan Mateo's contact information.
Has Alan Mateo been buying or selling shares of Veeva Systems?: Alan Mateo has not been actively trading shares of Veeva Systems during the past quarter. Most recently, Alan Mateo sold 3,391 shares of the business's stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $200.86, for a transaction totalling $681,116.26. Following the completion of the sale, the executive vice president now directly owns 21,983 shares of the company's stock, valued at $4,415,505.38. Learn More on Alan Mateo's trading history.
Who are Veeva Systems' active insiders?: Veeva Systems' insider roster includes Timothy Barabe (Director), Brent Bowman (CFO), Timothy Cabral (CFO), Paul Chamberlain (Director), Ronald Codd (Director), Jonathan Faddis (SVP), Peter Gassner (Founder, CEO, Director), Mary Hedley (Director), Frederic Lequient (SVP), Alan Mateo (EVP), Michele O'connor (CAO), Thomas Schwenger (COO), Paul Sekhri (Director), Matthew Wallach (President), and Eleni Zuppas (CMO). Learn More on Veeva Systems' active insiders.
Are insiders buying or selling shares of Veeva Systems?: In the last year, insiders at the technology company sold shares 14 times. They sold a total of 62,981 shares worth more than $12,743,625.70. The most recent insider tranaction occured on December, 4th when SVP Jonathan Faddis sold 1,694 shares worth more than $390,128.20. Insiders at Veeva Systems own 10.5% of the company. Learn More about insider trades at Veeva Systems.
Information on this page was last updated on 12/4/2024.

Alan Mateo Insider Trading History at Veeva Systems

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/23/2024	Sell	3,391	$200.86	$681,116.26	21,983
1/17/2024	Sell	910	$204.72	$186,295.20	21,983
12/22/2023	Sell	6,280	$190.00	$1,193,200.00	21,983
11/6/2023	Sell	6,280	$193.72	$1,216,561.60	19,769
10/25/2023	Sell	949	$200.00	$189,800.00	19,769
10/5/2023	Sell	13,801	$197.67	$2,728,043.67	20,718
12/7/2022	Sell	15,061	$165.83	$2,497,565.63	17,559
11/10/2021	Sell	2,347	$315.45	$740,361.15
10/11/2021	Sell	2,347	$285.90	$671,007.30
9/10/2021	Sell	2,347	$306.50	$719,355.50	5,476
7/9/2021	Sell	2,347	$319.91	$750,828.77	5,476
6/10/2021	Sell	2,347	$289.00	$678,283.00	4,944
5/10/2021	Sell	2,347	$255.96	$600,738.12	4,944
4/9/2021	Sell	2,347	$262.16	$615,289.52	4,944
4/5/2021	Sell	694	$265.98	$184,590.12	3,291
3/10/2021	Sell	2,347	$256.74	$602,568.78	4,291
2/5/2021	Sell	2,666	$290.21	$773,699.86	4,610
1/11/2021	Sell	2,347	$288.54	$677,203.38	5,192
1/5/2021	Sell	2,666	$270.02	$719,873.32	5,511
12/10/2020	Sell	2,347	$258.11	$605,784.17	12,611
12/7/2020	Sell	2,666	$271.24	$723,125.84	12,930
11/5/2020	Sell	2,666	$295.11	$786,763.26	13,831
10/5/2020	Sell	2,666	$275.14	$733,523.24	11,397
10/2/2020	Sell	687	$267.79	$183,971.73	10,319
9/8/2020	Sell	2,666	$259.35	$691,427.10	11,638
8/5/2020	Sell	2,665	$268.59	$715,792.35	12,538
7/6/2020	Sell	2,665	$244.20	$650,793.00	13,438
7/2/2020	Sell	445	$241.57	$107,498.65	12,118
6/5/2020	Sell	2,665	$203.35	$541,927.75	13,885
5/5/2020	Sell	2,665	$191.99	$511,653.35	14,785
4/27/2020	Sell	883	$190.00	$167,770.00	13,020
4/14/2020	Sell	867	$165.90	$143,835.30	14,770
4/6/2020	Sell	2,665	$151.87	$404,733.55	15,685
3/3/2020	Sell	431	$144.34	$62,210.54	15,820
1/28/2020	Sell	1,147	$142.40	$163,332.80	15,972
1/14/2020	Sell	603	$149.36	$90,064.08	17,722
1/2/2020	Sell	4,027	$142.17	$572,518.59	19,999
12/2/2019	Sell	4,026	$148.87	$599,350.62	18,967
11/1/2019	Sell	4,026	$142.51	$573,745.26	21,685
10/22/2019	Sell	890	$146.79	$130,643.10	18,811
10/14/2019	Sell	860	$154.65	$132,999.00	17,164
10/1/2019	Sell	4,026	$152.51	$614,005.26	19,440
9/17/2019	Sell	496	$146.15	$72,490.40	16,566
9/3/2019	Sell	4,026	$159.68	$642,871.68	18,718
8/1/2019	Sell	4,026	$165.52	$666,383.52	21,744
7/22/2019	Sell	883	$170.23	$150,313.09	18,870
7/15/2019	Sell	867	$175.58	$152,227.86	20,620
7/1/2019	Sell	4,026	$165.40	$665,900.40	22,896
6/11/2019	Sell	487	$163.95	$79,843.65	20,022
6/4/2019	Sell	4,539	$154.35	$700,594.65	22,174
5/1/2019	Sell	4,026	$141.12	$568,149.12	25,200
4/23/2019	Sell	1,059	$134.14	$142,054.26	22,326
4/16/2019	Sell	691	$134.06	$92,635.46	24,076
4/1/2019	Sell	4,026	$128.00	$515,328.00	26,352
3/13/2019	Sell	1,768	$120.00	$212,160.00	23,478
3/4/2019	Sell	4,025	$121.20	$487,830.00	29,631
1/15/2019	Sell	622	$97.61	$60,713.42	26,379
12/4/2018	Sell	538	$98.55	$53,019.90	25,167
10/16/2018	Sell	981	$92.07	$90,320.67	14,342
9/5/2018	Sell	555	$103.52	$57,453.60	13,147
8/13/2018	Sell	46,547	$85.42	$3,976,044.74
7/17/2018	Sell	876	$81.32	$71,236.32	13,023
6/21/2018	Sell	23,453	$85.00	$1,993,505.00	34,726
6/4/2018	Sell	345	$79.50	$27,427.50
4/16/2018	Sell	603	$72.59	$43,771.77	11,221
3/2/2018	Sell	340	$69.45	$23,613.00	9,811
1/16/2018	Sell	701	$58.85	$41,253.85	9,512
12/4/2017	Sell	532	$58.11	$30,914.52	8,294
10/16/2017	Sell	913	$59.14	$53,994.82
9/5/2017	Sell	528	$58.74	$31,014.72	6,985
8/14/2017	Sell	8,025	$62.89	$504,692.25	14,010
7/14/2017	Sell	10,028	$63.34	$635,173.52	7,989
6/14/2017	Sell	8,025	$59.75	$479,493.75	14,264
6/2/2017	Sell	1,181	$65.06	$76,835.86	7,420
5/15/2017	Sell	8,025	$56.57	$453,974.25	14,445
4/17/2017	Sell	10,083	$50.57	$509,897.31	8,479
3/20/2017	Sell	63,433	$49.90	$3,165,306.70	70,162
3/14/2017	Sell	5,350	$46.46	$248,561.00	13,166
3/3/2017	Sell	8,801	$44.85	$394,724.85	15,617
1/17/2017	Sell	3,748	$44.20	$165,661.60	8,624
12/5/2016	Sell	535	$42.64	$22,812.40	7,409
11/23/2016	Sell	52,339	$45.01	$2,355,778.39	6,409
10/14/2016	Sell	657	$38.21	$25,103.97	8,184
9/14/2016	Sell	2,716	$39.90	$108,368.40	9,150
9/6/2016	Sell	44,177	$40.55	$1,791,377.35	5,805
7/15/2016	Sell	659	$36.21	$23,862.39	6,814
6/3/2016	Sell	341	$34.42	$11,737.22	5,405
4/14/2016	Sell	604	$26.37	$15,927.48	5,009
1/13/2016	Sell	694	$24.45	$16,968.30	3,259
7/14/2015	Sell	699	$28.35	$19,816.65

Alan Mateo Buying and Selling Activity at Veeva Systems

Veeva Systems Company Overview

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Today's Range

Now: $224.15

$218.44

$227.10

50 Day Range

MA: $222.99

$208.78

$250.45

2 Week Range

Now: $224.15

$170.25

$258.93

Volume

2,374,109 shs

Average Volume

995,934 shs

Market Capitalization

$36.39 billion

P/E Ratio

55.35

Dividend Yield

N/A

Beta

0.82

Most People Are Dead Wrong.

From Brownstone Research | Ad